Therefore, we conducted the first systematic review and meta-analysis to the best of our knowledge, evaluating the association between visfatin and NAFLD, the presence and severity of hepatic steatosis, liver fibrosis, lobar inflammation, and NASH, in addition to possible gender differences. Here, NAMPT is linked to Hepatic fibrosis.